BioXcel Therapeutics (BTAI) Revenue (2022 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Revenue of $206000.0 for Q1 2026, up 22.62% year-over-year from $168000.0 in Q1 2025, and down 19.53% quarter-over-quarter from $256000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Revenue (2022 - 2026) Analysis & Trends
BioXcel Therapeutics' Revenue history runs 5 years deep, the most recent figure standing at $206000.0 for Q1 2026.
- In Q1 2026, Revenue rose 22.62% year-over-year to $206000.0; the TTM figure through Mar 2026 stood at $680000.0 (down 63.28% YoY), while the FY2025 annual figure was $642000.0, down 71.67% from the prior year.
- Revenue for Q1 2026 stood at $206000.0, down from $256000.0 in the prior quarter.
- The five-year high for Revenue was $1.1 million in Q2 2024, with the low at $98000.0 in Q3 2025.
- The 5-year median for Revenue is $238000.0 (2022), against an average of $324600.0.
- The sharpest annual moves came in 2024 and 2025: Revenue soared 182.52% in 2024, then plunged 89.13% in 2025.
- BioXcel Therapeutics' Revenue stood at $238000.0 in 2022, then jumped by 57.98% to $376000.0 in 2023, then slipped by 2.66% to $366000.0 in 2024, then sank by 30.05% to $256000.0 in 2025, then declined by 19.53% to $206000.0 in 2026.
- Business Quant data shows BTAI's Revenue at $206000.0 in Q1 2026, $256000.0 in Q4 2025, and $98000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.24 Mn | 24.24 Mn | 160,000.00 | 182,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 182,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Mar 31, 2025 | 168,000.00 |
| Dec 31, 2024 | 366,000.00 |
| Sep 30, 2024 | 214,000.00 |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 582,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Sep 30, 2023 | 341,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Mar 31, 2023 | 206,000.00 |
| Dec 31, 2022 | 238,000.00 |
| Sep 30, 2022 | 137,000.00 |